Literature DB >> 27003821

The Role of Dynamic Contrast-Enhanced MR in Evaluating Level III Collateral Circulation in a Rat Model of Acute Ischemic Stroke.

Hui Chen1, Nan Liu1, Ying Li1, Bing Wu2, Zihua Su3, Guangming Zhu4, Jun Hu5.   

Abstract

The study aimed to investigate the correlations between parameters of permeability magnetic resonance (MR) and the intensity of vasculature in the focal ischemic cortex of a rat model of middle cerebral artery occlusion. In the present study, sham operation or ischemic-reperfusion with tissue plasminogen activator (tPA) thrombolysis were performed in rats. Cranial MR scans and brain tissue samples were obtained from all animals. Brain slices were stained for immunohistological analyses with confocal fluorescence microscopy, and the intensities of microvessels and capillaries were calculated. Consistency between collateral circulation imaging classification and pathological vascular density was analyzed. We found that the K trans value and capillary intensity have the similar trends of declining and increasing, according to different time points, if compared with the sham operation group (P < 0.05). Permeability parameters have better correlations with capillary intensity, and K trans value had the best correlation at 4.5 h (kappa = 0.764, P < 0.001), while injection area under curve (IAUC) at 7 days (kappa = 0.725, P < 0.001). Susceptibility-weighted imaging (SWI) exhibited better correlation with microvessel intensity at both 3 days (kappa = 0.715, P < 0.001) and 7 days (kappa = 0.719, P < 0.001). In conclusion, the permeability parameters, such as IAUC and K trans map, can quantitatively assess capillary intensity, which may indicate angiogenesis categorized as level III collateral circulation after ischemic stroke.

Entities:  

Keywords:  Collateral circulation; Dynamic contrast-enhanced MR; Permeability; Stroke

Mesh:

Substances:

Year:  2016        PMID: 27003821     DOI: 10.1007/s12035-016-9844-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  22 in total

1.  Using standard first-pass perfusion computed tomographic data to evaluate collateral flow in acute ischemic stroke.

Authors:  Hui Chen; Bing Wu; Nan Liu; Max Wintermark; Zihua Su; Ying Li; Jun Hu; Yongwei Zhang; Weiwei Zhang; Guangming Zhu
Journal:  Stroke       Date:  2015-02-10       Impact factor: 7.914

2.  Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study.

Authors:  John M Starr; Andrew J Farrall; Paul Armitage; Brian McGurn; Joanna Wardlaw
Journal:  Psychiatry Res       Date:  2009-02-10       Impact factor: 3.222

3.  Dynamic changes in vascular permeability, cerebral blood volume, vascular density, and size after transient focal cerebral ischemia in rats: evaluation with contrast-enhanced magnetic resonance imaging.

Authors:  Chien-Yuan Lin; Chen Chang; Wai-Mui Cheung; Ming-Huang Lin; Jean-Ju Chen; Chung Y Hsu; Jyh-Horng Chen; Teng-Nan Lin
Journal:  J Cereb Blood Flow Metab       Date:  2008-05-14       Impact factor: 6.200

Review 4.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

5.  Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients.

Authors:  Jessica C Tan; William P Dillon; Songling Liu; Felix Adler; Wade S Smith; Max Wintermark
Journal:  Ann Neurol       Date:  2007-06       Impact factor: 10.422

6.  Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke.

Authors:  J Hom; J W Dankbaar; B P Soares; T Schneider; S-C Cheng; J Bredno; B C Lau; W Smith; W P Dillon; M Wintermark
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-14       Impact factor: 3.825

7.  Transient widespread blood-brain barrier alterations after cerebral photothrombosis as revealed by gadofluorine M-enhanced magnetic resonance imaging.

Authors:  Guido Stoll; Christoph Kleinschnitz; Sven G Meuth; Stefan Braeuninger; Chi Wang Ip; Carsten Wessig; Ingo Nölte; Martin Bendszus
Journal:  J Cereb Blood Flow Metab       Date:  2008-10-29       Impact factor: 6.200

8.  Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features.

Authors:  Fabien Scalzo; Jeffry R Alger; Xiao Hu; Jeffrey L Saver; Krishna A Dani; Keith W Muir; Andrew M Demchuk; Shelagh B Coutts; Marie Luby; Steven Warach; David S Liebeskind
Journal:  Magn Reson Imaging       Date:  2013-04-13       Impact factor: 2.546

9.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

Review 10.  Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.

Authors:  Anna K Heye; Ross D Culling; Maria Del C Valdés Hernández; Michael J Thrippleton; Joanna M Wardlaw
Journal:  Neuroimage Clin       Date:  2014-09-10       Impact factor: 4.881

View more
  3 in total

1.  The value of fragmented QRS in predicting the prognosis of chronic total occlusion patients with myocardial infarction history undergoing percutaneous coronary intervention: A 24-months follow-up study.

Authors:  Tiangui Yang; Xi Fu; Peng Fu; Jie Chen; Changlu Xu; Xiaoxia Liu; Tiesheng Niu
Journal:  Clin Cardiol       Date:  2021-02-16       Impact factor: 2.882

2.  Simultaneous Imaging of Cerebrovascular Structure and Function in Hypertensive Rats Using Synchrotron Radiation Angiography.

Authors:  Liping Wang; Zhihao Mu; Xiaojie Lin; Jieli Geng; Ti Qiao Xiao; Zhijun Zhang; Yongting Wang; Yongjing Guan; Guo-Yuan Yang
Journal:  Front Aging Neurosci       Date:  2017-11-02       Impact factor: 5.750

3.  Sigmoid Sinus Characteristics Correlate with Early Clinical and Imaging Surrogates in Anterior Circulation Ischemic Stroke.

Authors:  Slaven Pikija; Jozef Magdic; David S Liebeskind; Arthur Karamyan; Nele Bubel; Mark R McCoy; Johann Sellner
Journal:  Mol Neurobiol       Date:  2016-09-10       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.